Psychiatry

Embedding existential psychology within psychedelic science: reduced death anxiety as a mediator of the therapeutic effects of psychedelics.

Moreton, S. G., Szalla, L., Menzies, R. E., & Arena, A. F. | Psychopharmacology | 29 November 2019

Microdosing psychedelics: Motivations, subjective effects and harm reduction.

Lea, T., Amada, N., Jungaberle, H., Schecke, H., & Klein, M. | International Journal of Drug Policy | 25 November 2019

Psilocybin-assisted therapy for depression: How do we advance the field?

Meikle, S. E., Liknaitzky, P., Rossell, S. L., Ross, M., Strauss, N., Thomas, N., ... & Castle, D. J. | Australian & New Zealand Journal of Psychiatry | 22 November 2019

High-dose ketamine infusion for the treatment of posttraumatic stress disorder in combat veterans.

Ross, C., Jain, R., Bonnett, C. J., & Wolfson, P. | Annals of clinical psychiatry: official journal of the American Academy of Clinical Psychiatrists | 1 November 2019

Searching for Treatments for Cocaine Use Disorder: The Quest Continues.

Brady, K. T. | American Journal of Psychiatry | 1 November 2019

Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer.

dos Santos, R. G., Bouso, J. C., & Hallak, J. E. | BMC psychiatry | 28 October 2019

Esketamine Prevents Treatment-Resistant Depression Relapse.

Slomski, A. | Jama | 22 October 2019

The psychedelic renaissance: the next trip for psychiatry?

Kelly, J. R., Baker, A., Babiker, M., Burke, L., Brennan, C., & O’Keane, V. | Irish journal of psychological medicine | 23 September 2019

Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers

Hutten, N. R., Mason, N. L., Dolder, P. C., & Kuypers, K. P. | Frontiers in psychiatry | 13 September 2019

The Impact of Childhood Maltreatment on Intravenous Ketamine Outcomes for Adult Patients with Treatment-Resistant Depression

O’Brien, B., Lijffijt, M., Wells, A., Swann, A. C., & Mathew, S. J. | Pharmaceuticals | 11 September 2019

Exploring ayahuasca‐assisted therapy for addiction: A qualitative analysis of preliminary findings among an Indigenous community in Canada

Argento, E., Capler, R., Thomas, G., Lucas, P., & Tupper, K. W. | Drug and alcohol review | 5 September 2019

Hallucinogens and Their Therapeutic Use: A Literature Review

BEGOLA, M. J., & SCHILLERSTROM, J. E. | Journal of Psychiatric Practice | September 2019

Repeated ketamine injections in synergy with antidepressants for treating refractory depression: A case showing 6-month improvement.

Wang, M., Xiong, Z., Su, B., Wang, L., Li, Z., Yang, Y., & Fang, J. | Journal of clinical pharmacy and therapeutics | 30 August 2019

Attenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonism.

Williams, N. R., Heifets, B. D., Bentzley, B. S., Blasey, C., Sudheimer, K. D., Hawkins, J., ... & Schatzberg, A. F. | Molecular psychiatry | 29 August 2019

MDMA-assisted psychotherapy for posttraumatic stress disorder: A promising novel approach to treatment.

Vermetten, E., & Yehuda, R. | Neuropsychopharmacology | 27 August 2019

Ketamine and depression: a narrative review.

Corriger, A., & Pickering, G. | Drug design, development and therapy | 27 August 2019

Efficacy of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for posttraumatic stress disorder: A systematic review and meta-analysis.

Bahji, A., Forsyth, A., Groll, D., & Hawken, E. R. | Progress in Neuro-Psychopharmacology and Biological Psychiatry | 19 August 2019

Promises and concerns regarding the use of ketamine and esketamine in the treatment of depression.

Pérez‐Esparza, R., Kobayashi‐Romero, L. F., García‐Mendoza, A. M., Lamas‐Aguilar, R. M., & Fonseca‐Perezamador, A. | Acta Psychiatrica Scandinavica | August 2019

Classical psychedelics for the treatment of depression and anxiety: A systematic review.

Muttoni, S., Ardissino, M., & John, C. | Journal of affective disorders | 30 July 2019

Esketamine for treatment resistant depression.

Swainson, J., Thomas, R. K., Archer, S., Chrenek, C., MacKay, M. A., Baker, G., ... & Demas, M. L. | Expert Review of Neurotherapeutics | 16 July 2019

Effects of the synthetic psychedelic 2,5-dimethoxy-4-iodoamphetamine (DOI) on ethanol consumption and place conditioning in male mice.

Oppong-Damoah, A., Curry, K. E., Blough, B. E., Rice, K. C., & Murnane, K. S. | Psychopharmacology | 15 July 2019

First study of safety and tolerability of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in patients with alcohol use disorder: preliminary data on the first four participants

Sessa, B., Sakal, C., O’Brien, S., & Nutt, D. | BMJ Case Reports CP | 15 July 2019